Broadcast
FAX
DATE:
July 2, 2015
TO:
MnVFC Providers
FROM:
MnVFC Program
RE:
Guide for transitioning to 9vHPV*
Please route to:
 Clinical supervisor
 Medical director
 Clinic manager
 Clinic staff
 Pharmacy
 Vaccine staff
Answers to questions about transitioning to 9vHPV




ACIP has not stated a preference for any of the currently licensed HPV vaccines. All three protect against HPV 16
and 18, the types that cause about 66% of cervical cancers and the majority of other HPV-attributable cancers in
the United States.
Any available HPV vaccine product may be used to continue or complete the series for females, and 9vHPV or
4vHPV may be used to continue or complete the series for males if clinicians do not know what product was
previously given or do not have that product available.
There is no recommendation to give 9vHPV to persons who have previously completed the HPV vaccination series.
9vHPV vaccine is FDA licensed for males through age 15 years, however ACIP included an off-label
recommendation for use through age 26 years.
Guidelines for clinics transitioning from 4vHPV to 9vHPV

Providers who have 4vHPV in stock but prefer to vaccinate their MnVFC patients with 9vHPV will be able to order
9vHPV. However, clinics are encouraged to use up their 4vHPV doses while transitioning to an all-9vHPV stock.
This can be done in any of the following ways:
o
o
o
o
Doses of 4vHPV can be used to complete the series for patients who have received two doses of 4vHPV.
Use up 4vHPV doses in males since the additional protection from 9vHPV will mostly benefit females.
Start using 9vHPV vaccine for 11-12 year olds and complete HPV series in older adolescents with 4vHPV.
Reduce missed opportunities for timely HPV vaccination by vaccinating adolescents with whatever HPV
vaccine you currently have in stock.
If you have additional questions regarding the use of 9vHPV for your MnVFC patients contact the program at 651-2015522 or 800-657-3970 or email us at [email protected].
*Change in terminology
The new terminology for human papillomavirus (HPV) vaccines includes the valent number in front of the vaccine name.
For example: Cervarix is now referred to as 2vHPV instead of HPV2. The two Gardasil products are 4vHPV and 9vHPV.
Vaccine Preventable Disease Section
625 N Robert Street * P.O. Box 64975 * St Paul, Minnesota 55164-0975
www.health.state.mn.us/vfc
M n V FC P R O GR AM : 65 1 - 2 01 - 5 52 2 o r 80 0 - 6 57 - 3 97 0